CGVGX | RWIBX | CGVGX / RWIBX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 4 years | 22 years | - |
Gain YTD | 10.773 | 12.357 | 87% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 250 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 14.8B | 125B | 12% |
Annual Yield % from dividends | 1.33 | 1.05 | 127% |
Returns for 1 year | 17.70 | 18.20 | 97% |
Returns for 3 years | 11.49 | 1.61 | 713% |
Returns for 5 years | N/A | 35.89 | - |
Returns for 10 years | N/A | 45.76 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
GLDM | 50.76 | -0.09 | -0.18% |
SPDR® Gold MiniShares | |||
FSEP | 45.46 | -0.31 | -0.68% |
FT Cboe Vest US Equity Buffer ETF Sep | |||
EFAD | 37.85 | -0.30 | -0.79% |
ProShares MSCI EAFE Dividend Growers | |||
FAD | 141.65 | -1.29 | -0.90% |
First Trust Multi Cap Gr AlphaDEX® ETF | |||
FTXH | 27.10 | -0.89 | -3.18% |
First Trust Nasdaq Pharmaceuticals ETF |